Captor Therapeutics S.A. Capital Reinvestment Ratio
Captor Therapeutics S.A. capital reinvestment ratio. Captor Therapeutics S.A. (CTX) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (zł23.06 Million) in capital expenditures (zł83.00K). Check CTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Captor Therapeutics S.A. (2019–2019)
Capital reinvestment ratio of Captor Therapeutics S.A. from 2019 to 2019. This chart tracks Captor Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods. Also explore CTX net asset momentum to track the company's year-over-year net asset growth rate.
Captor Therapeutics S.A. Capital Reinvestment Ratio by Year (2019–2019)
Captor Therapeutics S.A. capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see Captor Therapeutics S.A. cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.05x | zł4.39 Million | zł229.00K | — |